Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis

por Jin, Jung-Kang, Tien, Pei-Chieh, Cheng, Chien-Jui, Song, Jian H., Huang, Cai, Lin, Sue-Hwa, Gallick, Gary E.
Publicado en Oncogene (2014)

Ligand-independent Activation of MET Through IGF-1/IGF-1R Signaling

por Varkaris, Andreas, Gaur, Sanchaika, Parikh, Nila U., Song, Jian H., Dayyani, Farshid, Jin, Jung-Kang, Logothetis, Christopher J., Gallick, Gary E.
Publicado 2013

Increased Serum Insulin-like Growth Factor-1 Levels are Associated with Prolonged Response to Dasatinib-based Regimens in Metastatic Prostate Cancer

por Dayyani, Farshid, Varkaris, Andreas, Araujo, John C., Song, Jian H., Chatterji, Tanushree, Trudel, Geralyn C., Logothetis, Christopher J., Gallick, Gary E.
Publicado 2013

RSK Promotes Prostate Cancer Progression in Bone through ING3, CKAP2 and PTK6-mediated Cell Survival

por Yu, Guoyu, Lee, Yu-Chen, Cheng, Chien-Jui, Wu, Chuan-Fen, Song, Jian H., Gallick, Gary E., Yu-Lee, Li-Yuan, Kuang, Jian, Lin, Sue-Hwa
Publicado en Mol Cancer Res (2014)

Combined Inhibition of IGF-1R/IR and Src Family Kinases Enhances Antitumor Effects in Prostate Cancer by Decreasing Activated Survival Pathways

por Dayyani, Farshid, Parikh, Nila U., Varkaris, Andreas S., Song, Jian H., Moorthy, Shhyam, Chatterji, Tanushree, Maity, Sankar N., Wolfe, Adam R., Carboni, Joan M., Gottardis, Marco M., Logothetis, Christopher J., Gallick, Gary E.
Publicado 2012

Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells

por Chatterji, Tanushree, Varkaris, Andreas S., Parikh, Nila U., Song, Jian H., Cheng, Chien-Jui, Schweppe, Rebecca E., Alexander, Stephanie, Davis, John W., Troncoso, Patricia, Friedl, Peter, Kuang, Jian, Lin, Sue-Hwa, Gallick, Gary E.
Publicado en Oncotarget (2015)

Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy

por Gaur, Sanchaika, Wen, Yunfei, Song, Jian H., Parikh, Nila U., Mangala, Lingegowda S., Blessing, Alicia M., Ivan, Cristina, Wu, Sherry Y., Varkaris, Andreas, Shi, Yan, Lopez-Berestein, Gabriel, Frigo, Daniel E., Sood, Anil K., Gallick, Gary E.
Publicado en Oncotarget (2015)

Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4

por Yu, Guoyu, Shen, Pengfei, Lee, Yu-Chen, Pan, Jing, Song, Jian H., Pan, Tianhong, Lin, Song-Chang, Liang, Xin, Wang, Guocan, Panaretakis, Theocharis, Logothetis, Christopher J., Gallick, Gary E., Yu-Lee, Li-Yuan, Lin, Sue-Hwa
Publicado en iScience (2021)

Cabozantinib Reverses Renal Cell Carcinoma-Mediated Osteoblast Inhibition in Three-Dimensional Co-culture In Vitro and Reduces Bone Osteolysis In Vivo

por Pan, Tianhong, Martinez, Mariane, Hubka, Kelsea M., Song, Jian H., Lin, Song-Chang, Yu, Guoyu, Lee, Yu-Chen, Gallick, Gary E., Tu, Shi-Ming, Harrington, Daniel A., Farach-Carson, Mary C., Lin, Sue-Hwa, Satcher, Robert L.
Publicado en Mol Cancer Ther (2020)

Inhibition of Cell Adhesion by an Anti-cadherin 11 Antibody Prevents Bone Metastasis

por Lee, Yu-Chen, Bilen, Mehmet Asim, Yu, Guoyu, Lin, Song-Chang, Huang, Chih-Fen, Ortiz, Angelica, Cho, Hyojin, Song, Jian H., Satcher, Robert L., Kuang, Jian, Gallick, Gary E., Yu-Lee, Li-Yuan, Huang, Wilber, Lin, Sue-Hwa
Publicado 2013

Targeting Constitutively Activated β(1) Integrins inhibits Prostate Cancer Metastasis

por Lee, Yu-Chen, Jin, Jung-Kang, Cheng, Chien-Jui, Huang, Chih-Fen, Song, Jian H., Huang, Miao, Brown, Wells S., Zhang, Sui, Yu-Lee, Li-Yuan, Yeh, Edward T., McIntyre, Bradley W., Logothetis, Christopher J., Gallick, Gary E., Lin, Sue-Hwa
Publicado 2013

Targeting DNA damage response in prostate cancer through inhibition of androgen receptor/CDC6-ATR-Chk1 signaling: Combined AR/CDC6 and Chk1/2 inhibition for PCa

por Karanika, Styliani, Karantanos, Theodoros, Li, Likun, Wang, Jianxiang, Park, Sanghee, Yang, Guang, Zuo, Xuemei, Song, Jian H., Maity, Sankar N., Manyam, Ganiraju C., Broom, Bradley, Aparicio, Ana M., Gallick, Gary, Troncoso, Patricia, Corn, Paul G., Navone, Nora, Zhang, Wei, Li, Shuhua, Thompson., Timothy C.
Publicado en Cell Rep (2017)

BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation()()

por Pan, Tianhong, Lin, Song-Chang, Yu, Kai-Jie, Yu, Guoyu, Song, Jian H., Lewis, Valerae O., Bird, Justin E., Moon, Bryan, Lin, Patrick P., Tannir, Nizar M., Jonasch, Eric, Wood, Christopher G, Gallick, Gary E., Yu-Lee, Li-Yuan, Lin, Sue-Hwa, Satcher, Robert L.
Publicado en Neoplasia (2017)

Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR-2 as Targets for Growth Inhibition of Prostate Cancer

por Varkaris, Andreas, Corn, Paul G., Parikh, Nila U., Efstathiou, Eleni, Song, Jian H., Lee, Yu-Chen, Aparicio, Ana, Hoang, Anh G., Gaur, Sanchaika, Thorpe, Lynnelle, Maity, Sankar N., Eli, Menashe Bar, Czerniak, Bogdan A., Shao, Yiping, Alauddin, Mian, Lin, Sue-Hwa, Logothetis, Christopher J., Gallick, Gary E.
Publicado en Clin Cancer Res (2015)

Radium 223 treatment increase immune checkpoint expression in extracellular vesicles from the metastatic prostate cancer bone microenvironment

por Vardaki, Ioulia, Corn, Paul, Gentile, Emanuela, Song, Jian H, Madan, Namrata, Hoang, Anh, Parikh, Nila, Guerra, Leah, Lee, Yu-Chen, Lin, Song-Chang, Yu, Guoyu, Santos, Elmer, Melancon, Marites P., Troncoso, Patricia, Navone, Nora, Gallick, Gary E., Efstathiou, Eleni, Subudhi, Sumit K., Lin, Sue-Hwa, Logothetis, Christopher J., Panaretakis, Theocharis
Publicado en Clin Cancer Res (2021)

Targeting Src and tubulin in mucinous ovarian carcinoma

por Liu, Tao, Hu, Wei, Dalton, Heather J., Choi, Hyun Jin, Huang, Jie, Kang, Yu, Pradeep, Sunila, Miyake, Takahito, Song, Jian H., Wen, Yunfei, Lu, Chunhua, Pecot, Chad V., Bottsford-Miller, Justin, Zand, Behrouz, Jennings, Nicholas B, Ivan, Cristina, Gallick, Gary E., Baggerly, Keith A, Hangauer, David G., Coleman, Robert L., Frumovitz, Michael, Sood, Anil K.
Publicado 2013

Chromatin Regulator, CHD1, Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer

por Zhao, Di, Cai, Li, Lu, Xin, Liang, Xin, Li, Jiexi, Chen, Peiwen, Ittmann, Michael, Shang, Xiaoying, Jiang, Shan, Li, Haoyan, Meng, Chenling, Flores, Ivonne, Song, Jian H., Horner, James W, Lan, Zhengdao, Wu, Chang-Jiun, Li, Jun, Chang, Qing, Chen, Ko-Chien, Wang, Guocan, Deng, Pingna, Spring, Denise J., Wang, Y. Alan, DePinho, Ronald A.
Publicado en Cancer Discov (2020)

Enzalutamide-induced “BRCAness” and PARP inhibition is a synthetic lethal therapy for castration-resistant prostate cancer

por Li, Likun, Karanika, Styliani, Yang, Guang, Wang, Jiangxiang, Park, Sanghee, Broom, Bradley, Manyam, Ganiraju C., Wu, Wenhui, Luo, Yong, Basourakos, Spyridon, Song, Jian H., Gallick, Gary E., Karantanos, Theodoros, Korentzelos, Dimitrios, Azad, Abul Kalam, Kim, Jeri, Corn, Paul G., Aparicio, Ana M., Logothesis, Christopher J., Troncoso, Particia, Timothy, Heffernan, Toniatti, Carlo, Lee, Hyun-Sung, Lee, Ju-Seog, Zuo, Xuemei, Chang, Wenjun, Yin, Jianhua, Thompson, Timothy C.
Publicado en Sci Signal (2017)

THE CLINICAL AND BIOLOGICAL SIGNIFICANCE OF MIR-224 EXPRESSION IN COLORECTAL CANCER METASTASIS

por Ling, Hui, Pickard, Karen, Ivan, Cristina, Isella, Claudio, Ikuo, Mariko, Mitter, Richard, Spizzo, Riccardo, Bullock, Marc, Braicu, Cornelia, Pileczki, Valentina, Vincent, Kimberly, Pichler, Martin, Stiegelbauer, Verena, Hoefler, Gerald, Almeida, Maria I., Hsiao, Annie, Zhang, Xinna, Primrose, John, Packham, Graham, Liu, Kevin, Bojja, Krishna, Gafà, Roberta, Xiao, Lianchun, Rossi, Simona, Song, Jian H., Vannini, Ivan, Fanini, Francesca, Kopetz, Scott, Zweidler-McKay, Patrick, Wang, Xuemei, Ionescu, Calin, Irimie, Alexandru, Fabbri, Muller, Lanza, Giovanni, Hamilton, Stanley R., Berindan-Neagoe, Ioana, Medico, Enzo, Mirnezami, Alex, Calin, George A., Nicoloso, Milena S.
Publicado en Gut (2015)